Research reportEnhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial
Introduction
The WHO ranks unipolar major depression as the fourth most important cause of premature mortality and disability (Murray and Lopez, 1997), and yet the treatment of this illness remains unsatisfactory. In terms of efficacy, antidepressants have not improved since their introduction in the 1950s. In a comprehensive study of more than 9000 clinical reports, the US Agency for Health Care Policy and Research found that the response rate, defined as a 50% or greater improvement on a standardised depression scale, had not changed with the introduction of the selective serotonin reuptake inhibitors in the last twenty years. Treatment by the active drug produced a response in 50% of patients as compared to 32% on placebo (Agency for Health Care Policy and Research, 1999).
One of the most robust findings in the biochemistry of major depression is of low plasma and red cell folate in these patients. Patients with low plasma folate responded less well to treatment by antidepressants (Reynolds et al., 1970, Abou-Saleh and Coppen, 1986, Abou-Saleh and Coppen, 1989, Carney et al., 1990, Fava et al., 1997).
These observations prompted us to carry out a randomised placebo-controlled trial to see if the co-administration of folic acid with fluoxetine would enhance its antidepressant effect.
Section snippets
Study details
A randomised, double-blind, parallel group, placebo-controlled trial, completed in a multicentre general practice setting, as outlined in Fig. 1.
Patients
One hundred and twenty seven patients attending 19 general practitioners with a special interest in depression, were enrolled in the study using a randomised schedule stratified for sex. The General Practitioners were known to be interested in depressive illness and attended training sessions in the use of the DSM-III-R (American Psychiatric
Results
There were no significant differences between the two treatment groups in all baseline characteristics.
The mean age of all 62 patients on fluoxetine plus folic acid was 41.9 (S.D. 12.0) and the mean age of all 65 patients on fluoxetine plus placebo was 44.3 (S.D. 14.6). There was no significant difference between the ages of the two treatment groups or between men and women.
Fifty-one patients (33 women and 18 men) on fluoxetine plus folic acid and 58 patients (36 women and 22 men) on fluoxetine
Discussion
It has now been established in many investigations that folic acid will lower plasma homocysteine (Homocysteine Lowering Trialists’ Collaboration, 1998).
This study demonstrates that only in female depressed patients does the co-administration of folic acid substantially and significantly improve the response to fluoxetine. Only 6.1% of the women given fluoxetine and folic acid failed to respond (according to the >50% improvement criterion) as compared to 38.9% given fluoxetine alone. Using a
Acknowledgements
Dr. David Horrobin was an unfailing source of help and encouragement during all stages of the trial.
The study was funded by Scotia Pharmaceuticals. The GP trialists were recruited and trained by Professor G. Beaumont and Dr. M. Gringras. The GPs participating in the study were Doctors:
M. Adler (Harrow n=7), W. Aitchison (Houston n=7), T. Baldwin (Cwmbran n=6), A. Berger (Milton Keynes n=7), G. Bhatia (Nottingham n=7), J. Bochsler (London n=7), P. Brahma (West Yorks n=7, A. Bremner (Rutherglen n
References (22)
- et al.
The biology of folate in depression: implications for nutritional hypotheses of the psychoses
J. Psychiatr. Res.
(1986) - et al.
Red cell folate concentrations in psychiatric patients
J. Affect. Disord.
(1990) - et al.
Folic acid enhances lithium prophylaxis
J. Affect. Disord.
(1986) - et al.
Depression and tetrahydrobiopterin: the folate connection
J. Affect. Disord.
(1989) - et al.
Enhancement of recovery from psychiatric illness by methylfolate
Lancet
(1990) - et al.
Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives
Atherosclerosis
(1999) - et al.
Subjective side-effects of amitriptyline and lithium in affective disorders
Br. J. Psychiatry
(1983) - et al.
Serum and red blood cell folate in depression
Acta Psychiatr. Scand.
(1989) - Agency for Health Care Policy and Research, March, 1999. Treatment of Depression — Newer Pharmacotherapies. Summary,...
Diagnostic and Statistical Manual of Mental Disorders
(1987)